Literature DB >> 19151065

Assessment and management of non-visible haematuria in primary care.

John D Kelly1, Derek P Fawcett, Lawrence C Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19151065     DOI： 10.1136/bmj.a3021

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  Toward a simple diagnostic index for acute uncomplicated urinary tract infections.

Authors:  Bart J Knottnerus; Suzanne E Geerlings; Eric P Moll van Charante; Gerben Ter Riet
Journal:  Ann Fam Med       Date:  2013 Sep-Oct       Impact factor: 5.166

2.  Japanese guidelines of the management of hematuria 2013.

Authors:  Shigeo Horie; Shuichi Ito; Hirokazu Okada; Haruhito Kikuchi; Ichiei Narita; Tsutomu Nishiyama; Tomonori Hasegawa; Hiroshi Mikami; Kunihiro Yamagata; Tomoji Yuno; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2014-10       Impact factor: 2.801

Review 3.  Renal and cardiac assessment of living kidney donor candidates.

Authors:  Ngan N Lam; Krista L Lentine; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2017-04-03       Impact factor: 28.314

Review 4.  Pathogenesis of glomerular haematuria.

Authors:  Claudia Yuste; Eduardo Gutierrez; Angel Manuel Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Alberto Ortiz; Jesus Egido; Manuel Praga; Juan Antonio Moreno
Journal:  World J Nephrol       Date:  2015-05-06

Review 5.  CT urography for hematuria.

Authors:  Nigel C Cowan
Journal:  Nat Rev Urol       Date:  2012-03-13       Impact factor: 14.432

6.  Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care.

Authors:  Sarah J Price; Elizabeth A Shephard; Sally A Stapley; Kevin Barraclough; William T Hamilton
Journal:  Br J Gen Pract       Date:  2014-09       Impact factor: 5.386

7.  A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.

Authors:  Laimonis Kavalieris; Paul J O'Sullivan; James M Suttie; Brent K Pownall; Peter J Gilling; Christophe Chemasle; David G Darling
Journal:  BMC Urol       Date:  2015-03-27       Impact factor: 2.264

8.  UroMark-a urinary biomarker assay for the detection of bladder cancer.

Authors:  Andrew Feber; Pawan Dhami; Liqin Dong; Patricia de Winter; Wei Shen Tan; Mónica Martínez-Fernández; Dirk S Paul; Antony Hynes-Allen; Sheida Rezaee; Pratik Gurung; Simon Rodney; Ahmed Mehmood; Felipe Villacampa; Federico de la Rosa; Charles Jameson; Kar Keung Cheng; Maurice P Zeegers; Richard T Bryan; Nicholas D James; Jesus M Paramio; Alex Freeman; Stephan Beck; John D Kelly
Journal:  Clin Epigenetics       Date:  2017-01-31       Impact factor: 6.551

9.  Clinical features of bladder cancer in primary care.

Authors:  Elizabeth A Shephard; Sally Stapley; Richard D Neal; Peter Rose; Fiona M Walter; William T Hamilton
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

10.  A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace.

Authors:  Tanzeela Khalid; Paul White; Ben De Lacy Costello; Raj Persad; Richard Ewen; Emmanuel Johnson; Chris S Probert; Norman Ratcliffe
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.